24 September, 2017 by The TZ Newswire Staff Comments Off on 7 Reasons Your Obamacare Premium Could Soar by a Double-Digit Percentage in 2018
7 Reasons Your Obamacare Premium Could Soar by a Double-Digit Percentage in 2018
In just over five weeks, open enrollment for the Affordable Care Act (ACA), which is best known as Obamacare, will begin. The upcoming enrollment period could very well rival the first enrollment period (Oct. 2013 – March 2014) as the most challenging yet, given the uncertainties surrounding what might happen to now-former President Barack Obama’s hallmark healthcare legislation.
24 September, 2017 by The TZ Newswire Staff Comments Off on If You Like Dividends, You Should Love These 3 Stocks
If You Like Dividends, You Should Love These 3 Stocks
Income investors aren’t suffering from a lack of stock choices right now. But while generous yields aren’t very hard to find today, the combination of steady income and solid growth is much more rare. Below, we’ll look at why McDonald’s (NYSE: MCD), Hasbro (NASDAQ: HAS), and Procter & Gamble (NYSE: PG) have what it takes to deliver on both of these requirements.
24 September, 2017 by The TZ Newswire Staff Comments Off on Best Buy: The Coca-Cola Co vs. PepsiCo, Inc. vs. Procter & Gamble Co
Best Buy: The Coca-Cola Co vs. PepsiCo, Inc. vs. Procter & Gamble Co
They are three of the biggest names among dividend investors. Coca-Cola (NYSE: KO), Procter & Gamble (NYSE: PG) , and PepsiCo (NYSE: PEP) have been offering investors dividend increases for a combined 162 consecutive years. That’s the key to building dynastic wealth: the compounding power of dividend increases.
24 September, 2017 by The TZ Newswire Staff Comments Off on Top clicks this week on Abnormal Returns
Top clicks this week on Abnormal Returns
Top clicks this week
24 September, 2017 by The TZ Newswire Staff Comments Off on AbbVie’s Unfazed by the Risk of Generic Humira
AbbVie’s Unfazed by the Risk of Generic Humira
Over 60% of AbbVie Inc.’s (NYSE: ABBV) sales come from demand for Humira — an autoimmune-disease drug prescribed to patients with a variety of conditions — that racks up sales of $16 billion per year. Humira is also world’s top selling medicine.
AbbVie’s heavy reliance on Humira has investors nervous about what happens when Humira loses its patent protection, but perhaps, those worries are overblown based on what AbbVie’s management is telling investors.
24 September, 2017 by The TZ Newswire Staff Comments Off on Here’s Why You Didn’t Get the Job
Here’s Why You Didn’t Get the Job
Even in a healthy job market, some people find themselves on the outside looking in. They may look good on paper, have good backgrounds, and seem very employable, but they fail over and over at getting interviews or landing a job.
Having been the person doing the hiring in a number of different industries — retail, media, manufacturing, and even high-end summer camps — I’ve noticed that many people who keep not getting hired make the same mistakes over and over. Some make errors that keep them from getting an interview, while others get that far, but botch the interview.
24 September, 2017 by The TZ Newswire Staff Comments Off on Trading Places: Cobalt, FinaCom, Goldman Sachs, BNP Paribas
Trading Places: Cobalt, FinaCom, Goldman Sachs, BNP Paribas
Catch up on last week’s executive moves.